AF

Afya Limited

AFYAConsumer DefensiveNASDAQ

Education & Training Services · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.70B
+11.9% YoY
Net Income
$752.5M
+19.2% YoY
EBITDA
$1.67B
+21.6% YoY
Free Cash Flow
$386.6M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ RSI OverboughtRSI 88.3, above 70, stock may be overbought
Oct 19▼ RSI OverboughtRSI 82.1, above 70, stock may be overbought
About Afya Limited

Headquartered within the consumer defensive sector, Afya Limited focuses on Education & Training Services services and products. Afya Limited operates as a medical education group in Brazil. At a $1.34B market cap, Afya Limited ranks as a small-cap company within consumer defensive. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions.

Where AFYA stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, AFYA finished 4.92% above its 150-day moving average ($14.24) and 5.73% above its 200-day moving average ($14.13). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is AFYA overbought or oversold?

At the October 20, 2026 close, AFYA's RSI(14) was 88.3, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.34B
P/E (TTM)9.20
Fwd P/E7.49
EPS$1.64
Beta0.37
52W Change+3.5%
Dividend Yield4.35%
ROE16.7%
Analysis

On the balance sheet, AFYA has $1.01B in cash with $3.12B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $386.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 16.7%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.4% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $2.33B (2022) to $3.70B (2025), reflecting a 59% increase over the period.

The relatively low beta of 0.37 suggests AFYA is a less volatile holding compared to the broader index. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AFYA.

Links
More Consumer Defensive stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms